Get started
Author

María Auxiliadora Gómez‐España

Observed names: M. A. Gomez-España, M. A. Gómez-España, M. Auxiliadora Gómez-España, M.A. Gómez-España, M.Auxiliadora Gomez-España, Ma Auxiliadora Gómez-España, Maria A. Gomez-España, Maria Auxiliadora Gomez-España, Maria Auxiliadora Gómez-España, Maria Auxilidora Gomez-España, María Auxiliadora Gómez-España, Mª A. Gómez-España, Mª Auxiliadora Gómez-España
Observed institutions: Instituto de Salud Carlos III, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Roche (Spain), Centro de Investigación Biomédica en Red de Cáncer, Sociedad Española de Oncología Médica, University of Córdoba
ORCID: 0000-0001-9128-2944
Observed ORCID: 0000-0001-9128-2944
OpenAlex ID: A5113792216
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
2018 · M. A. Gómez-España, J. Gallego, et al. · Clinical & Translational Oncology · 62
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
2020 · Marta Toledano-Fonseca, M. Teresa Cano, et al. · Cancers · 54
PDF
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
2021 · Mª A. Gómez-España, A. F. Montes, et al. · Clinical & Translational Oncology · 48
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
2019 · Ana Vivancos, Enrique Aranda, et al. · Scientific Reports · 47
Update on the management of elderly patients with colorectal cancer
2023 · Gemma Soler-González, Javier Sastre-Valera, et al. · Clinical & Translational Oncology · 28
PDF
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
2023 · María Victoria García-Ortiz, Pablo Cano-Ramírez, et al. · Clinical Epigenetics · 27
PDF
SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013
2013 · E. Casado-Saenz, J. Feliu, et al. · Clinical & Translational Oncology · 24
Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs).
2019 · Javier Sastre, Jose María Vieitez, et al. · Journal of Clinical Oncology · 23
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
2016 · Cristina Morales-Estevez, Juan De la Haba-Rodriguez, et al. · Frontiers in Immunology · 13
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
2021 · Barbara Manzanares-Martin, Arancha Cebrián Aranda, et al. · Journal for ImmunoTherapy of Cancer · 11
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
2023 · M. Toledano-Fonseca, M.A. Gómez-España, et al. · Biomedicine & Pharmacotherapy · 10
Metabolic shift underlies tumor progression and immune evasion in S‐nitrosoglutathione reductase‐deficient cancer
2023 · Rafael Mena‐Osuna, Ana Mantrana, et al. · The Journal of Pathology · 8
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
2021 · Elena Élez, María Auxiliadora Gómez-España, et al. · British Journal of Cancer · 8
PDF
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
2024 · P. García-Alfonso, E. Elez, et al. · ESMO Open · 4
PDF
Regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy (PChT) patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive Tumor Therapy (TTD).
2016 · Alfredo Carrato, Manuel Benavides, et al. · Journal of Clinical Oncology · 4
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
2025 · Ana Mantrana, María Teresa Sánchez-Montero, et al. · Laboratory Investigation · 3
A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project
2024 · Pablo Flores-Paco, Alicia Vargas-Aliaga, et al. · Journal of Neuro-Oncology · 3
PDF
The CIRCULATE Spain study: Circulating tumor DNA based decision for adjuvant treatment in localized colon cancer.
2023 · Noelia Tarazona, Juan Antonio Carbonell-Asins, et al. · Journal of Clinical Oncology · 3
PDF
Comparison of three molecular methods to detect mutations in KRAS, NRAS, BRAF and PIK3CA in metastatic colorectal cancer (mCRC).
2016 · Cristina Santos, Rocio Garcia-Carbonero, et al. · Journal of Clinical Oncology · 1
The genomic profile (GP) of early breast cancer (EBC): Daily practice analysis.
2016 · Cristina Morales-Estevez, Alberto Moreno, et al. · Journal of Clinical Oncology · 1
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer
2026 · Marta Toledano-Fonseca, Icíar de la Fuente, et al. · Molecular Diagnosis & Therapy
PDF
SEOM–GEMCAD–TTD clinical guidelines for anal cancer (2025)
2026 · Mónica Guillot Morales, Ana Fernández Montes, et al. · Clinical & Translational Oncology
PDF
Correction: Update on the management of elderly patients with colorectal cancer
2023 · Gemma Soler-González, Javier Sastre-Valera, et al. · Clinical & Translational Oncology
PDF
POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers
2019 · M E Elez Fernandez, M.A. Gómez-España, et al. · Annals of Oncology
A patient with waxy plaques on the nose
2016 · Maria Esther Sanchez-Garcia, Maria Auxiliadora Gomez-España, et al. · Medicina Clínica (English Edition)
Works count: 31
Citation count: 382
H-index: 10
I10-index: 11
Year
Topic
Type